Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics
Trial Snapshot
- Phase
- Not Applicable
- Status
- Enrolling By Invitation
- Sponsor
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Erythema
Study Overview
Brief Summary
The purpose of this study is to assess how human skin reacts and how sunscreens and sun protection fabrics protect in natural sunlight compared to their labeled claims, indoor testing methods (existing or modified) and instructions.
Detailed Description
To evaluate the difference in the level of erythema and persistent pigment darkening sun protection following a single period of natural sunlight exposure or laboratory solar simulator exposure afforded by application of sunscreens, use of fabrics, and use of pass through glass filters.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- Double (Participant, Outcomes Assessor)
Eligibility Criteria
- Ages
- 15 Years to 90 Years (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Fitzpatrick Type I, II, III, IV or V type skin.
- •Must be able to be exposed to natural sunlight for up to 4 hours in a prone position
- •Able to read, write, speak and understand the English language.
- •Has personally read, signed, and dated the Informed Consent Form (including HIPAA disclosure) and Photograph Release
- •Generally in good health based on medical history reported by the subject
- •Healthy male or female subjects with no history or evidence of clinically relevant medical disorder, as determined from a brief medical history interview.
- •Willing and able to follow the study instructions, including:
- •Remain outdoors exposed to the sun or in the laboratory for up to 4 hours on Day 1 during the study with exposed skin on back protected by sunscreens and fabrics
- •Apply the specific sunscreens and fabrics to designated sites on the back and lie motionless.
- •No visual signs of recent sun exposure to the back.
- •No sunscreens or lotions recently used on the back.
- •Attend scheduled visits and intend to successfully complete the study
- •Stay out of the sun or stay indoors from sun exposure until after observation on Day
- •Women are discouraged from using a bra that applies pressure to the skin site areas that may make it difficult to assess erythema or PPD on Day
- •Refrain from using other sunscreen products or tanning bed use during the duration of the study.
Exclusion Criteria
- •Individuals with known allergies or sensitivities to sunscreens or any ingredient contained in the test products or common topical skincare products, including adhesives.
- •Perceptible erythema, PPD on the back as determined by the PI or designee.
- •Women known to be pregnant or nursing.
- •Individuals with any disease or condition of the skin (e.g., active [i.e. flaring] eczema or psoriasis, skin cancer, atypical nevus, polymorphic light eruption (PMLE), porphyria, systemic lupus erythematous (SLE), xeroderma pigmentosa (XP)) that could interfere with the study or increase risk to the subject.
- •Individuals with self-reported UNCONTROLLED metabolic conditions, such as diabetes, hypertension, hyper/hypothyroidism, hypercholesterolemia
- •Subjects who are taking medication for chronic conditions that may make a subject more sun sensitive (e.g., Tetracyclines, antifungals, certain diuretics, etc.)
- •Skin diseases on tested sites (e.g., photosensitivity disorders, etc.), which may influence the outcome of the study
- •An individual who has any condition which in the PI's judgment makes the candidate an inappropriate subject for study participation
- •Individuals with a condition or situation which, in the PI's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study
- •Individual viewed by the PI as not being able to complete the study
Arms & Interventions
Location
Location and Intensity of Exposure to Sunlight otc sunscreens sun protection fabrics optical filters
Intervention: otc sunscreens (Drug)
Location
Location and Intensity of Exposure to Sunlight otc sunscreens sun protection fabrics optical filters
Intervention: sun protection fabrics (Other)
Location
Location and Intensity of Exposure to Sunlight otc sunscreens sun protection fabrics optical filters
Intervention: Optical Filters (Other)
Single Duration or SPF Test
Single exposure of interventions or multiple exposures of interventions (SPF or PPD-PF tests) otc sunscreens sun protection fabrics optical filters
Intervention: otc sunscreens (Drug)
Single Duration or SPF Test
Single exposure of interventions or multiple exposures of interventions (SPF or PPD-PF tests) otc sunscreens sun protection fabrics optical filters
Intervention: sun protection fabrics (Other)
Single Duration or SPF Test
Single exposure of interventions or multiple exposures of interventions (SPF or PPD-PF tests) otc sunscreens sun protection fabrics optical filters
Intervention: Optical Filters (Other)
Outcomes
Primary Outcomes
Erythema
Time Frame: 16-24 hours post exposure to natural sunlight
• Erythema was assessed using a scale of 0 = no perceptible sun induced skin reaction, 1 = perceptible erythema but spotty or without clear borders (\<1 MED); 2 = minimal erythema over the entire site with distinct borders (1 MED reaction); 3 = more than minimal; 4 = a serious erythema; and 5 = edema and blisters. Determination made by blinded evaluator on-site or using chroma-meter and photographs.
Persistent Pigment Darkening (PPD)
Time Frame: 16-24 hours post exposure to natural sunlight
Persistent Pigment Darkening was assessed using a scale of 0 = no perceptible sun induced skin reaction, 1 = perceptible but spotty or without clear borders (\<1 MPPDD); 2 = minimal PPD over the entire site with distinct borders (1 MPPDD reaction); 3 = more than minimal; 4 = a serious erythema; and 5 = edema and blisters Determination made by blinded evaluator on-site or using chroma-meter and photographs.
Secondary Outcomes
No secondary outcomes reported